Anti-Human DLL3 Recombinant Antibody
-
产品编号
YR1386
-
别名
科研级 Rovalpituzumab ( 洛伐妥珠单抗 ), Anti-DLL3 Recombinant Antibody, Research Grade Rovalpituzumab
-
规格
- 1mg
- 5mg
产品介绍
| Catalog Number | YR1386 |
| Alias | 科研级 Rovalpituzumab ( 洛伐妥珠单抗 ), Anti-DLL3 Recombinant Antibody, Research Grade Rovalpituzumab |
| Size | 1mg, 5mg |
| Molecular Name | Rovalpituzumab |
| CAS Number | 1613313-01-1 |
| Target | DLL3[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial. |
| Remarks | This product is for research use only. |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5栋
-
销售微信
-
官方公众号
-
400-621-6806 -
18630936064（微信同号） -
周一至周五 8:30-18:00 -
-
0
-
